Igle J. de Jong

5.5k total citations · 1 hit paper
149 papers, 3.9k citations indexed

About

Igle J. de Jong is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Igle J. de Jong has authored 149 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Pulmonary and Respiratory Medicine, 50 papers in Radiology, Nuclear Medicine and Imaging and 39 papers in Surgery. Recurrent topics in Igle J. de Jong's work include Prostate Cancer Treatment and Research (48 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Radiopharmaceutical Chemistry and Applications (26 papers). Igle J. de Jong is often cited by papers focused on Prostate Cancer Treatment and Research (48 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Radiopharmaceutical Chemistry and Applications (26 papers). Igle J. de Jong collaborates with scholars based in Netherlands, United States and Belgium. Igle J. de Jong's co-authors include Philip H. Elsinga, Jan Pruim, Willem Vaalburg, Hildo J.K. Ananias, H.J.A. Mensink, Wijnand Helfrich, Han J.A. Mensink, A.J. Breeuwsma, Anna M. Leliveld and Peter F.A. Mulders and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Igle J. de Jong

141 papers receiving 3.8k citations

Hit Papers

Comparison of Immediate vs Deferred Cytoreductive Nephrec... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib
    2018 306 citations Igle J. de Jong, Bertrand Tombal et al. profile →

Peers

Igle J. de Jong
Daniel A. Hamstra United States
Nicola S. Russell Netherlands
Matthias Heck Germany
Eyal Mishani Israel
Matthew J. Krasin United States
I.D. Kaplan United States
Lawrence Kleinberg United States
Matthew Smith United States
Roger von Moos Switzerland
John L. Villano United States
Daniel A. Hamstra United States
Igle J. de Jong
Citations per year, relative to Igle J. de Jong Igle J. de Jong (= 1×) peers Daniel A. Hamstra

Countries citing papers authored by Igle J. de Jong

Since Specialization
Citations

This map shows the geographic impact of Igle J. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igle J. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igle J. de Jong more than expected).

Fields of papers citing papers by Igle J. de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igle J. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igle J. de Jong. The network helps show where Igle J. de Jong may publish in the future.

Co-authorship network of co-authors of Igle J. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Igle J. de Jong. A scholar is included among the top collaborators of Igle J. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igle J. de Jong. Igle J. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bangma, Chris H., Maarten J. Bijlsma, Alfons C.M. van den Bergh, et al.. (2025). External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study. BMC Cancer. 25(1). 149–149. 1 indexed citations
2.
3.
4.
Jong, Igle J. de, et al.. (2024). Treatment of acute phase of Peyronie’s disease with tamoxifen and vardenafil/tadalafil off label. University of Groningen research database (University of Groningen / Centre for Information Technology). 14(1). 15–20.
5.
Wit, Jaron G. de, et al.. (2024). Fluorescence‐guided surgery using cetuximab‐800CW in patients with penile carcinoma. British Journal of Urology. 134(2). 268–275. 3 indexed citations
6.
Brouwer, Charlotte L., Ben Vanneste, Igle J. de Jong, et al.. (2023). Pretrial Quality Assurance for Hypofractionated Salvage Radiation Therapy After Prostatectomy in the Multi-Institutional PERYTON-trial. Advances in Radiation Oncology. 9(2). 101379–101379. 1 indexed citations
7.
8.
Stelwagen, J., Coby Meijer, Annemiek Walenkamp, et al.. (2021). Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment. Cancers. 13(22). 5675–5675. 6 indexed citations
9.
Antunes, Inês F., Aren van Waarde, Rudi Dierckx, et al.. (2021). Synthesis and Evaluation of 18F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-18F-Fluoro-5α-Dihydrotestosterone. Journal of Nuclear Medicine. 62(8). 1140–1145. 8 indexed citations
10.
Yakar, Derya, et al.. (2021). Single-center versus multi-center biparametric MRI radiomics approach for clinically significant peripheral zone prostate cancer. Insights into Imaging. 12(1). 150–150. 21 indexed citations
11.
Rosati, S., et al.. (2016). EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study. International Journal of Molecular Sciences. 17(10). 1650–1650. 5 indexed citations
12.
Carlucci, Giuseppe, Anneke Kuipers, Hildo J.K. Ananias, et al.. (2015). GRPR-selective PET imaging of prostate cancer using [18F]-lanthionine-bombesin analogs. Peptides. 67. 45–54. 29 indexed citations
13.
Glaudemans, Andor W.J.M., et al.. (2013). Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 40(S1). 41–47. 19 indexed citations
14.
15.
Oosting, Sjoukje F., Thijs H. Oude Munnink, Marjolijn N. Lub–de Hooge, et al.. (2012). Serial Zr-89-bevacizumab PET Imaging in Metastatic Renal Cell Carcinoma Patients treated with Sunitinib, or Bevacizumab Plus Interferon.. Data Archiving and Networked Services (DANS).
16.
Jong, Igle J. de, Heleen A. Reinders‐Messelink, Kiek Tates, et al.. (2012). Activity and participation of children and adolescents with unilateral congenital below elbow deficiency: An online focus group study. Journal of Rehabilitation Medicine. 44(10). 885–892. 19 indexed citations
17.
Zheng, Yu, et al.. (2010). A Novel I-123-Cubane Labelled Bombesin for Imaging GRP Receptor-Expressing Prostate Cancer Cells. Data Archiving and Networked Services (DANS). 1 indexed citations
18.
Jong, Igle J. de, et al.. (2007). LHRH agonists in prostate cancer: frequency of treatment, serum testosterone measurement and castrate level: consensus opinion from a roundtable discussion. Current Medical Research and Opinion. 23(5). 1077–1080. 20 indexed citations
19.
Jong, Igle J. de, et al.. (1998). The significance of plasma membrane transport in the bioavailability of thyroid hormone. Clinical Endocrinology. 48(1). 1–8. 18 indexed citations
20.
Jong, Igle J. de, Marcel E. Reinders, Janneau van Kranenburg, Johan De Meester, & G. G. Persijn. (1996). Multiorgan donation in the Netherlands: limited by consent and policy. Transplant International. 9(4). 430–432. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel A. Hamstra Breakdown of academic impact, for papers by Nicola S. Russell Breakdown of academic impact, for papers by Matthias Heck Breakdown of academic impact, for papers by Eyal Mishani Breakdown of academic impact, for papers by Matthew J. Krasin Breakdown of academic impact, for papers by I.D. Kaplan Breakdown of academic impact, for papers by Lawrence Kleinberg Breakdown of academic impact, for papers by Matthew Smith Breakdown of academic impact, for papers by Roger von Moos Breakdown of academic impact, for papers by John L. Villano
Rankless by CCL
2026